Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
UPCOMING SESSIONS
in
ET
Tue, Jul 21, 2026
5:00 – 6:00 AM Bangkok
Taking Control of Your Health Care: Navigating and Maximizing the Patient Portal
Tricia Walker
Click Here To Register
View all
UPCOMING SESSIONS
in
ET
Tue, Jul 21, 2026 · 5:00 – 6:00 AM Bangkok
Taking Control of Your Health Care: Navigating and Maximizing the Patient Portal
Tricia Walker
Click Here To Register
View all sessions
All Upcoming Sessions
3
JUL
21
Taking Control of Your Health Care: Navigating and Maximizing the Patient Portal
Tue, Jul 21, 2026 · 5:00 – 6:00 AM Bangkok
Tricia Walker
Register
JUL
23
Diagnosis of Cardiac Amyloidosis
Thu, Jul 23, 2026 · 5:00 – 6:00 AM Bangkok
Faizi Jamal
Register
JUL
24
Part 2: The Passion That Sustains You (Present)
Fri, Jul 24, 2026 · 5:00 – 6:00 AM Bangkok
Hamide Eygoren
Register
Patisiran (ALN-TTR02)
Home
Patisiran (ALN-TTR02)
Jul 04, 2018
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Read more
Alnylam® Pharmaceuticals
Read more
Alnylam Announces Receipt of Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
Read more
FDA Approves Alnylam’s Onpattro for Polyneuropathy of hATTR Amyloidosis
Read more
Subscribe to
